Pregnancy, p53 and breast cancer risk

The age at which a woman becomes pregnant could influence whether she subsequently develops breast cancer.

Written byVicki Glaser
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

BETHESDA — Early pregnancy is known to protect women from breast cancer, but the mechanism by which this is achieved remains unclear. In 23 October Proceedings of the National Academy of Sciences, Lakshmi Sivaraman and colleagues at the Baylor College of Medicine (BCM), Houston, Texas, challenge one leading theory and propose new ideas to explain their unexpected finding that the tumor suppressor gene, p53, seems to have a significant role to play.

"Before we started this study, we had no idea this [effect] would turn out to be related to p53," said Bert O'Malley, Chairman of the Michael DeBakey Center at BCM and the senior author on the paper.

The puzzle O'Malley and others in the field are trying to solve is why women who have a full-term pregnancy by age 19 have a 50% reduction in their lifetime breast cancer risk. A first pregnancy in the mid-20s appears to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies